Research Report
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2014; 20(15): 4362-4369
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4362
Table 4 Adverse effects in each therapy
Adverse eventsEsomeprazole therapy
Lansoprazole therapy
G1G2G3Total, %G1G2G3Total, %
Diarrhea323136, 27%337141, 31%
Bitter taste133016, 12%142016, 12%
Nausea1001, 0.7%1001, 0.7%
Vomiting2013, 2.2%0000, 0%
Eruption1203, 2.2%2103, 2.2%
Headache0000, 0%2002, 1.5%
Fatigue1001, 0.7%0000, 0%
Appetite loss2103, 2.2%1001, 0.7%
Stomatitis0000, 0%1001, 0.7%
Cheilitis0000, 0%2002, 1.5%
Thirst2002, 1.5%0000, 0%
Belch1001, 0.7%0000, 0%
Bad breath1001, 0.7%0000, 0%
Sore throat1001, 0.7%0000, 0%
Joint paint1001, 0.7%0000, 0%
Leg edema0000, 0%1001, 0.7%
Chest discomfort2002, 1.5%0000, 0%
Floating1001, 0.7%0000, 0%
Abdominal wind1001, 0.7%0000, 0%
Constipation2002, 1.5%2002, 1.5%
Pruritus ani0000, 0%1001, 0.7%
Total649275, 56%6010171, 53%

  • Citation: Nishida T, Tsujii M, Tanimura H, Tsutsui S, Tsuji S, Takeda A, Inoue A, Fukui H, Yoshio T, Kishida O, Ogawa H, Oshita M, Kobayashi I, Zushi S, Ichiba M, Uenoyama N, Yasunaga Y, Ishihara R, Yura M, Komori M, Egawa S, Iijima H, Takehara T. Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan. World J Gastroenterol 2014; 20(15): 4362-4369
  • URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4362.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v20.i15.4362